Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12Cl2F3N7O2S |
| Formula Wt. | 506.30 |
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
http://clinicaltrials.gov/show/NCT01425008
ASK1 inhibitor.
Cyclic depsipeptide is a secondary metabolite i...
CDK9 inhibitor.
SARS-CoV-2 inhibitor
Organosulfur found in garlic.
Coccidiostat; dihydrofolate reductase inhibitor...
Diterpene found in brewed, unfiltered coffee; F...
Steroidal alkaloid found in Fritillaria; M2 mAC...
Flavonol found in various plant sources.
Endogenous sphingolipid involved in cell signal...
Dihydropyridine, FIASMA; L-type Ca2+ channel bl...
Endogenous peptide hormone, involved in secreti...
β-lactam carbapenem; penicillin binding protei...
Quaternary ammonium cationic surfactant, dissoc...
NSAID; COX-2 inhibitor.
Potential ATP-sensitive K+ channel blocker, pot...
Cell membrane permeability modulator, topoisome...
CDK1/2 inhibitor.
Synthetic glycyrrhetinic acid derivative; 11β-...